Loading...
Loading...
BIOR| Name | Value |
|---|---|
| Revenues | 0.0M |
| Cost of Revenue | 0.1M |
| Gross Profit | -0.1M |
| Operating Expense | 23.3M |
| Operating I/L | -23.3M |
| Other Income/Expense | -50.1M |
| Interest Income | 0.0M |
| Pretax | -73.5M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -73.5M |
Biora Therapeutics, Inc. is a biotechnology company specializing in the development of oral biotherapeutics. The company's targeted therapeutics program focuses on using ingestible smart capsules for precise delivery of therapeutics in the gastrointestinal tract, particularly for treating inflammatory bowel diseases. Additionally, its systemic therapeutics program utilizes ingestible capsules for needle-free delivery of biotherapeutics directly into the intestinal mucosa to enhance systemic uptake. Biora Therapeutics also develops diagnostic devices to characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth, through various technologies for on-site disease diagnosis.
